The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research
Open accessAbstract
Life sciences researchers are under pressure to innovate faster than ever. Big data offer the promise of unlocking novel insights and accelerating breakthroughs. Ironically, although more data are available than ever, only a fraction is being integrated, understood, and analyzed. The challenge lies in harnessing volumes of data, integrating the data from hundreds of sources, and understanding their various formats. New technologies such as cognitive computing offer promise for addressing this challenge because cognitive solutions are specifically designed to integrate and analyze big datasets. Cognitive solutions can understand different types of data such as lab values in a structured database or the text of a scientific publication. Cognitive solutions are trained to understand technical, industry-specific content and use advanced reasoning, predictive modeling, and machine learning techniques to advance research faster. Watson, a cognitive computing technology, has been configured to support life sciences research. This version of Watson includes medical literature, patents, genomics, and chemical and pharmacological data that researchers would typically use in their work. Watson has also been developed with specific comprehension of scientific terminology so it can make novel connections in millions of pages of text. Watson has been applied to a few pilot studies in the areas of drug target identification and drug repurposing. The pilot results suggest that Watson can acc…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, AI models developed by IBM Watson have been used to predict individual responses to different diabetes medications, helping clinicians tailor treatments to each patient’s unique genetic and metabolic profile (54).”
From Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review (2025) · cites this paper as [54]
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Data-intensive applications, challenges, techniques and technologies: A survey on Big Data
Philip Chen, C. L., & Zhang, C.-Y. (2014) · Information Sciences · doi:10.1016/j.ins.2014.01.015 · Cited by 3,047
Big data analytics in healthcare: promise and potential
Raghupathi, W., & Raghupathi, V. (2014) · Health Information Science and Systems · doi:10.1186/2047-2501-2-3 · Cited by 3,034
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Edward Jenner and the History of Smallpox and Vaccination
Riedel, S. F. (2005) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2005.11928028 · Cited by 965
Modha, D. S., Ananthanarayanan, R., Esser, S. K., Ndirango, A., Sherbondy, A. J., & Singh, R. (2011) · Communications of the ACM · doi:10.1145/1978542.1978559 · Cited by 345
The $2.6 Billion Pill — Methodologic and Policy Considerations
Avorn, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500848 · Cited by 322
The role of serendipity in drug discovery
Ban, T. A. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.3/tban · Cited by 294
National Health Expenditure Projections, 2014–24: Spending Growth Faster Than Recent Trends
Keehan, S. P., Cuckler, G. A., Sisko, A. M., Madison, A. J., Smith, S. D., Stone, D. A., Poisal, J. A., Wolfe, C. J., & Lizonitz, J. M. (2015) · Health Affairs · doi:10.1377/hlthaff.2015.0600 · Cited by 229
Research works printed but not linked: 1
- Modha Dharmendra, 2011, Unite neuroscience, supercomputing, and nanotechnology to discover, demonstrate and deliver the brain’s core algorithms, Commun ACM, 54, 62
Cited by
Sorted by citations
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Personalized medicine: motivation, challenges, and progress
Goetz, L. H., & Schork, N. J. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.006 · Cited by 976
Artificial intelligence for clinical trial design
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.05.005 · Cited by 672
Artificial Intelligence Transforms the Future of Health Care
Noorbakhsh-Sabet, N., Zand, R., Zhang, Y., & Abedi, V. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.017 · Cited by 626
Aceto, G., Persico, V., & Pescapé, A. (2018) · Journal of Network and Computer Applications · doi:10.1016/j.jnca.2018.02.008 · Cited by 504
Metadata
- Authors
- Chen, Y., Elenee Argentinis, J., & Weber, G.
- Affiliations
- IBM Research - Almaden (US)
- ORCID
- Chen, Ying
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 38
- Issue
- 4
- Pages
- 688-701
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2342299174
- Cited by
- 466
- References
- 28
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 42 · 2023: 38 · 2022: 37 · 2021: 68 · 2020: 58 · 2019: 66 · 2018: 63 · 2017: 31 · 2016: 8
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Therapeutics (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- IBM Watson, cognitive computing, big data, biology research, drug target identification, drug repurposing, scientific literature analysis, data integration, genomic data, patents, machine learning
- MeSH terms
- Biological Science Disciplines, Cognition, Humans, Research, Databases, Factual, Drug Delivery Systems, Informatics, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
